Skip to content
Learning that drives better investment decisions

China Resources Pharmaceutical Group – World Class Benchmarking

Company: China Resources Pharmaceutical Group Limited

Bloomberg ticker: 3320 HK

Market cap: US$4,418m

Background: China Resources Pharmaceutical Group Limited is a pharmaceutical company and part of the Chinese state-owned conglomerate China Resources. The company is the largest manufacturer of non-prescription drugs in China and has one of the largest pharmacy networks in the country.

World Class Benchmarking of China Resources Pharmaceutical Group



 

  • Profitable Growth rank of 9 was same compared to the prior period’s 9th rank
  • This is poor performance compared to 380 large Health Care companies worldwide
  • Profitability rank of 9 was worse than its Growth rank of 4
  • Profitability rank of 9 was the same compared to the prior period’s 9th rank
  • This is poor performance compared to peers
  • Growth rank of 4 was up compared to the prior period’s 7th rank
  • This is above-average performance compared to peers

 


DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.